Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia

Journal of Clinical Psychiatry

Volumn 68, Issue 4, 2007, Pages 566-571

  Morken, Gunnar ^a,b   Grawe, Rolf W ^a,c   Widen, Jan H ^a,d  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c SINTEF   (Norway)

^d TELEMARK HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; FEMALE; FOLLOW UP; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SINGLE BLIND PROCEDURE; SOCIAL ADAPTATION; TREATMENT OUTCOME;

EID: 34247533210     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0409     Document Type: Article

References (25)

1. Nose M, Barbui C, Gray R, et al. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry 2003; 183:197-206
2. Petersen L, Jeppesen P, Thorup A, et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005;331:602
3. Pharoah FM, Rathbone J, Mari JJ, et al. Family intervention for schizophrenia. Cochrane Database Syst Rev 2003;CD000088
4. Zygmunt A, Olfson M, Boyer CA, et al. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002;159:1653-1664
5. Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev 2000; CD001089
6. Grawe RW, Falloon IRH, Widen JH, et al. Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Acta Psychiatr Scand 2006;114:328-336
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
8. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Patient Version. Washington, DC: American Psychiatric Press; 1997
9. Falloon IR. Optimal treatment for psychosis in an international multisite demonstration project. Optimal Treatment Project Collaborators. Psychiatr Serv 1999;50:615-618
10. Falloon IRH, Fadden G. Integrated Mental Health Care. Cambridge, England: Cambridge University Press; 1993
11. Tarrier N, Barrowclough C, Vaughn C, et al. The community management of schizophrenia: a controlled trial of a behavioural intervention with families to reduce relapse. Br J Psychiatry 1988;153:532-542
12. Magana AB, Goldstein JM, Karno M, et al. A brief method for assessing expressed emotion in relatives of psychiatric patients. Psychiatry Res 1986;17:203-212
13. Wearden AJ, Tarrier N, Barrowclough C, et al. A review of expressed emotion research in health care. Clin Psychol Rev 2000;20:633-666
14. Ventura J, Green MF, Shaner A, et al. Training and quality assurance with the Brief Psychiatric Rating Scale: the drift busters. Int J Methods Psychiatr Res 1993;3:221-244
15. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-1991
16. Kemp R, Hayward P, Applewhaite G, et al. Compliance therapy in psychotic patients: randomised controlled trial. BMJ 1996;312:345-349
17. Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry 1998;172:413-419
18. Fernandez RS, Evans V, Griffiths RD, et al. Educational interventions for mental health consumers receiving psychotropic medication: a review of the evidence. Int J Ment Health Nurs 2006;15: 70-80
19. Gray R, Wykes T, Gournay K. From compliance to concordance: a review of the literature of interventions to enhance compliance with antipsychotic medication. Int J Ment Health Nurs 2002;9:277-284
20. Byerly MJ, Fisher R, Carmody T, et al. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005;66:997-1001
21. O'Donnell C, Donohoe G, Sharkey L, et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ 2003;327:834
22. Kissling W. The current unsatisfactory state of relapse prevention in schizophrenic psychoses: suggestions for improvement. Clin Neuropharmacol 1991;14(suppl 2):S33-S44
23. Weiden P, Rapkin B, Mott T, et al. Rating of Medication Influences (ROMI) scale in schizophrenia. Schizophr Bull 1994;20:297-310
24. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997;23:637-651
25. Kamali M, Kelly L, Gervin M, et al. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr Serv 2001;52:161-163, 166